NPPA issued the retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg + Metformin Hydrochloride (As Extended Release) IP 1000 mg +Empagliflozin 25 mg for M/s Exemed Pharmaceuticals (Manufacturer) & M/s Primus Remedies Pvt. Ltd. (Marketer)

Feb 26, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 25, 2026, issued the retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg + Metformin Hydrochloride (As Extended Release) IP 1000 mg +Empagliflozin 25 mg for M/s Exemed Pharmaceuticals (Manufacturer) & M/s Primus Remedies Pvt. Ltd. (Marketer).

The following has been stated: -

• Each film-coated bilayer tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg + Metformin Hydrochloride (As Extended Release) IP 1000 mg +Empagliflozin 25 mg for M/s Exemed Pharmaceuticals (Manufacturer) & M/s Primus Remedies Pvt. Ltd. (Marketer) will be Rs. 22.77/-.

 

[Notification No.:19 (5041)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT